跳转至内容
Merck
CN

A2487

Sigma-Aldrich

磺胺甲恶唑,成品溶液

100 mg/mL in DMSO

登录查看公司和协议定价

别名:
复方新诺明, TMP-SMX
经验公式(希尔记法):
C14H18N4O3 · 5 C10H11N3O3S
CAS号:
分子量:
1556.71
UNSPSC代码:
51101500
NACRES:
NA.85

形式

liquid

质量水平

浓度

100 mg/mL in DMSO

颜色

colorless to faint yellow

抗生素抗菌谱

Gram-negative bacteria
Gram-positive bacteria
fungi
parasites

作用机制

DNA synthesis | interferes

运输

dry ice

储存温度

−20°C

InChI

1S/C14H18N4O3.C10H11N3O3S/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15;1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h5-7H,4H2,1-3H3,(H4,15,16,17,18);2-6H,11H2,1H3,(H,12,13)

InChI key

WZRJTRPJURQBRM-UHFFFAOYSA-N

应用

复方新诺明已被用作抗菌剂。

生化/生理作用

复方新诺明是甲氧苄啶和磺胺甲恶唑的组合,可通过阻止核苷酸的生物合成来干扰叶酸在细菌细胞中的细胞代谢。甲氧苄啶与二氢叶酸还原酶(DHFR)结合,从而抑制二氢叶酸(DHF)还原为四氢叶酸(THF),从而产生抗菌作用。新诺明通过阻止对氨基苯甲酸向辅酶二氢叶酸的转化来干扰敏感微生物中核酸的合成。这些作用的最终结果是抑制胸腺嘧啶核苷的合成,从而阻止细菌 DNA 的合成。

包装

1ml

制备说明

使用甲氧苄啶:磺胺甲恶唑的 1:5 混合物制备

其他说明

保存于密闭容器内,置于干燥通风处。

象形图

Health hazard

警示用语:

Warning

危险声明

危险分类

Aquatic Chronic 3 - Repr. 2

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

MMWR. Morbidity and mortality weekly report, 62(46), 914-916 (2013-11-22)
In March 2012, a Salvadoran-American boy aged 7 years living in Maryland developed three slightly painful, well-demarcated, flat, gray-brown patches on his torso. A dermatologist in Washington, DC, suspected a fixed drug eruption (an erythema multiforme-like adverse drug reaction that
Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study.
Diaz MA, et al.
Journal of Clinical Microbiology, 48, 2840-2845 (2010)
Escherichia coli resistant to quinolones in a neonatal unit.
Ruiz Del Castillo B, et al.
Journal of Medical Microbiology, 60, 1713-1716 (2011)
Amy J Pate et al.
The American journal of emergency medicine, 32(2), 135-138 (2013-11-19)
Methicillin-resistant Staphylococcus aureus (MRSA) infections are becoming increasingly prevalent in both community and hospital settings. Certain strains are notorious for causing skin and soft tissue infections in patients with no established risk factors. In this article, we report our findings
Lise Denoeud-Ndam et al.
Journal of acquired immune deficiency syndromes (1999), 65(2), 198-206 (2013-11-14)
Malaria during pregnancy has serious consequences that are worsened by HIV infection. Malaria preventive measures for HIV-infected pregnant women include cotrimoxazole (CTX) prophylaxis given to prevent HIV-related opportunistic infections and also protective against malaria, or intermittent preventive treatment (IPTp) with

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门